Molecular Data Inc.

Molecular Data Inc.

OOTC:MKDTY
0.00
USD
0.00
(0.00%)
Molecular Data Inc.
OTC:MKDTY
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
TTM
CNY
418.03
547.87
1,180.43
1,913.32
981.84
- -
Revenue per Share
-14.86
-14.06
-33.2
-28.04
-42.4
- -
Basic EPS, GAAP
-19.33
-24.6
-17.85
-14.15
-30.27
- -
Free Cash Flow per Basic Share
- -
0.05
0.89
- -
- -
- -
Dividend per Share
- -
0.85
-8.93
-31.36
-3.58
-6.64
Book Value per Share
- -
0.65
-9.24
-31.59
-3.65
-6.67
Tangible Book Value per Share
8
8
8
7
8
9
Basic Weighted Avg Shares
3,206
4,202
9,053
13,207
7,596
- -
Sales/Revenue/Turnover
-3.3
-2.14
-2.6
-1.46
-4.36
- -
Operating Margin (%)
1
1
2
3
2
- -
Depreciation Expense
-114
-108
-255
-194
-328
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-3.55
-2.57
-2.81
-1.47
-4.32
- -
Profit Margin (%)
- -
77
112
-189
-29
-58
Working Capital
- -
75
178
- -
20
20
LT Debt
- -
6
-62
-216
-28
-59
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'20
Dec'20
Jun'21
ST Debt
33
51
82
LT Borrowings
- -
- -
- -
LT Finance Leases
18
20
20
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
347
8
9
Market Capitalization
- -
- -
- -

Working Capital

CNY

•

in mil. unless spec.
Jun'20
Dec'20
Jun'21
Total Current Assets
752
663
744
Cash, Cash Equivalents & STI
410
347
349
Accounts Receivable, Net
133
6
8
Inventories
3
3
4
Total Current Liabilities
661
693
802
Payables & Accruals
505
519
651
ST Debt
33
51
82
Deferred Revenue
123
117
69

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-87.12%
Free Cash Flow
- -
- -
139.82%
Net Income, GAAP
- -
- -
69.49%
Sales/Revenue/Turnover
- -
- -
-42.48%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
4,024
4,063
13,207
2020
- -
- -
- -
- -
7,596
2021
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
-4.28
-8.74
-28.04
2020
- -
- -
- -
- -
-42.4
2021
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
Business
Molecular Data Inc. (MKDTY) operates as a technology-driven platform providing one-stop services for the chemical and pharmaceutical industries, including online sales of over 10 million chemical compounds, big data analytics on molecular structures and properties, supply chain management solutions, and research and development support tools. The company offers core products and services such as the Molbase.cn B2B marketplace for bulk chemical procurement; AI-powered molecular search and prediction databases covering synthesis routes, patents, and supplier matching; laboratory services encompassing custom synthesis, compound screening, and CRO (contract research organization) capabilities; and digital platforms like ChemNow for real-time pricing and inventory data across thousands of suppliers. Headquartered in Shanghai, China, and founded in 2013, Molecular Data primarily serves pharmaceutical companies, biotech firms, research institutions, and chemical manufacturers in China and internationally, with expanding operations in Asia-Pacific regions. In recent developments within the last two years, the company has pursued strategic expansions in AI-driven drug discovery tools and formed alliances with leading Chinese chemical producers to enhance its supply chain ecosystem; it also launched enhanced blockchain-based traceability services for chemical sourcing amid growing regulatory demands in 2024.